{
  "pmc_id": "PMC2597732",
  "reading_started": "06:01:2015:14:07",
  "reading_complete": "06:01:2015:14:07",
  "submitter": "MITRE",
  "reader_type": "human",
  "model_relation": "extension",
  "model_elements": [],
  "extracted_information": {
    "interaction_type": "increases",
    "negative_information": false,
    "participant_a": {
      "entity_type": "protein",
      "entity_text": "FGFR3",
      "in_model": true,
      "identifier": "Uniprot:FGFR3_HUMAN",
      "features": [{
        "site": 650,
        "from_base": "K",
        "to_base": "E"
      }],
      "not_features": []
    },
    "participant_b": {
      "entity_type": "protein",
      "entity_text": "STAT1",
      "in_model": false,
      "identifier": "Uniprot:STAT1_HUMAN",
      "features": [],
      "not_features": []
    }
  },
  "evidence": ["In this experiment, only the\nK650M and K650E mutants induced activatory phosphorylation of\nSTAT1(Y701); the other mutants as well as wild-type FGFR3 caused\nno detectable phosphorylation (Fig. 1).", "Note that only K650M and K650E-FGFR3 mutants cause STAT1\nphosphorylation, as evidenced by western blotting with antibody recognizing STAT1 only when phosphorylated at Y701 (P-Y701-STAT1).", "Previously, we showed that K650E-FGFR3 interacts with STAT1 in\ncells and phosphorylates STAT1(Y701) in a cell-free kinase assay,\nthus serving as a STAT1 tyrosine kinase [11]."]
}
